Expression Table for this CRE
| CNhs12200 | Dendritic Cells - plasmacytoid, donor3 | 12.6 |
| CNhs12120 | Renal Proximal Tubular Epithelial Cell, donor3 | 11.6 |
| CNhs12472 | K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 10.3 |
| CNhs11845 | biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10.3 |
| CNhs12581 | Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 8.7 |
| CNhs11891 | hereditary spherocytic anemia cell line:WIL2-NS | 8.6 |
| CNhs12392 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 8.2 |
| CNhs12181 | CD19+ B Cells (pluriselect), donor090309, donation3 | 8.2 |
| CNhs11741 | diffuse large B-cell lymphoma cell line:CTB-1 | 7.9 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 7.4 |
| CNhs12920 | Fibroblast - Villous Mesenchymal, donor3 | 7.3 |
| CNhs13054 | acute myeloid leukemia (FAB M1) cell line:HYT-1 | 7.1 |
| CNhs12319 | globus pallidus, adult, donor10252 | 6.6 |
| CNhs12530 | neutrophil PMN, donor3 | 6.6 |
| CNhs12062 | Bronchial Epithelial Cell, donor6 | 6.5 |
| CNhs12448 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 6.2 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 6.2 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 6.1 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 6.0 |
| CNhs14591 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 5.7 |
| CNhs11842 | fibrous histiocytoma cell line:GCT TIB-223 | 5.7 |
| CNhs12930 | Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 5.6 |
| CNhs12552 | CD133+ stem cells - adult bone marrow derived, pool1 | 5.6 |
| CNhs11959 | Neutrophils, donor2 | 5.4 |
| CNhs12004 | Smooth Muscle Cells - Brain Vascular, donor3 | 5.1 |
| CNhs12325 | epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 5.1 |
| CNhs14532 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 5.0 |
| CNhs11830 | peripheral neuroectodermal tumor cell line:KU-SN | 5.0 |
| CNhs11858 | mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 4.9 |
| CNhs14549 | globus pallidus, adult, donor10258 | 4.9 |
| CNhs14540 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 4.9 |
| CNhs12575 | Basophils, donor3 | 4.9 |
| CNhs12094 | Corneal Epithelial Cells, donor2 | 4.8 |
| CNhs14600 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 4.7 |
| CNhs12196 | Dendritic Cells - plasmacytoid, donor2 | 4.7 |
| CNhs11886 | chronic myeloblastic leukemia (CML) cell line:KCL-22 | 4.6 |
| CNhs12371 | mesenchymal precursor cell - cardiac, donor4 | 4.5 |
| CNhs12080 | Meningeal Cells, donor2 | 4.5 |
| CNhs14490 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 4.5 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 4.4 |
| CNhi10939_ACC | Human primary dermal lymphatic vascular endothelial cells, biol_rep1 | 4.4 |
| CNhs11825 | large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 4.4 |
| LShi10030_ACAGTG-CACTATG | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep3 | 4.2 |
| CNhs12904 | H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 4.2 |
| CNhs11945 | meningioma cell line:HKBMM | 4.1 |
| CNhs12547 | Eosinophils, donor1 | 4.1 |
| CNhs14561 | Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 4.0 |
| CNhs14618 | putamen, adult, donor10258 | 3.9 |
| CNhs12427 | MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 3.9 |
| CNhs14588 | Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 3.8 |